Novelix Pharma, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹45 crore and net profit of ₹1.56 crore for the September 2026 quarter.
Novelix Pharma. (BSE: NOVELIX) closed at ₹65.34 on 20 Nov 2026, up 8.3% over the past year. Its market capitalisation is ₹186 crore and it trades at 40.0 times earnings.
Incorporated in 1994, Novelix Pharmaceuticals Ltd trades in Pharmaceuticals and related products , shares, and securities
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.